Pendal Group’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Pendal Group's AMGN Position: Q3 2022 in Review
Pendal Group sold out of Amgen (AMGN) in Q3 2022, closing a stake of 6,609 shares — an estimated $1.61M sold.
Pendal Group first reported a position in AMGN in Q2 2017 and held it in 13 quarters. The position peaked at $15.7M in Q3 2017. 2,323 funds tracked by Wall St. Rank hold AMGN as of Q3 2022.
- Pendal Group reported no remaining Amgen position as of Q3 2022 after selling out during the quarter.
- Pendal Group sold 6,609 Amgen shares in Q3 2022, an estimated $1.61M.
- Pendal Group first reported a position in Amgen in Q2 2017 and held it in 13 quarters.
- Pendal Group's Amgen position peaked at $15.7M in Q3 2017.
- 2,323 funds tracked by Wall St. Rank held Amgen as of Q3 2022.
Based on Pendal Group's 13F filing for Q3 2022, filed 18 Oct 2022.